Bn2DT3A, a Chelator for 68Ga Positron Emission Tomography: Hydroxide Coordination Increases Biological Stability of [68Ga][Ga(Bn2DT3A)(OH)]

Inorg Chem. 2022 Oct 31;61(43):17059-17067. doi: 10.1021/acs.inorgchem.2c01992. Epub 2022 Oct 17.

Abstract

The chelator Bn2DT3A was used to produce a novel 68Ga complex for positron emission tomography (PET). Unusually, this system is stabilized by a coordinated hydroxide in aqueous solutions above pH 5, which confers sufficient stability for it to be used for PET. Bn2DT3A complexes Ga3+ in a hexadentate manner, forming a mer-mer complex with log K([Ga(Bn2DT3A)]) = 18.25. Above pH 5, the hydroxide ion coordinates the Ga3+ ion following dissociation of a coordinated amine. Bn2DT3A radiolabeling displayed a pH-dependent speciation, with [68Ga][Ga(Bn2DT3A)(OH)]- being formed above pH 5 and efficiently radiolabeled at pH 7.4. Surprisingly, [68Ga][Ga(Bn2DT3A)(OH)]- was found to show an increased stability in vitro (for over 2 h in fetal bovine serum) compared to [68Ga][Ga(Bn2DT3A)]. The biodistribution of [68Ga][Ga(Bn2DT3A)(OH)]- in healthy rats showed rapid clearance and excretion via the kidneys, with no uptake seen in the lungs or bones.

MeSH terms

  • Animals
  • Chelating Agents* / chemistry
  • Gallium Radioisotopes* / chemistry
  • Hydroxides
  • Positron-Emission Tomography / methods
  • Radiopharmaceuticals / chemistry
  • Rats
  • Tissue Distribution

Substances

  • Gallium Radioisotopes
  • Chelating Agents
  • hydroxide ion
  • Hydroxides
  • Radiopharmaceuticals